USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
USANA Health Sciences, Inc. (USNA) filed this Current Report on Form 8-K on July 22, 2025. The filing announces the financial results for the second quarter ended June 28, 2025. The report incorporates by reference a press release and a "Management Commentary" document furnished as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. Investors must refer to the attached Exhibits 99.1 and 99.2 for detailed financial figures.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended June 28, 2025.
Guidance, Outlook, and Management Commentary
- Management Commentary: The Company announced it will post a document titled "Management Commentary" on its corporate website.
- Conference Call: Executives will hold a conference call with investors, broadcast via the World Wide Web and telephone. The call will feature brief remarks followed by a question-and-answer session.
- Disclosure Status: The information in this report is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not intended to be incorporated by reference into registration statements under the Securities Act of 1933.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Press Release (Exhibit 99.1).
- Review the "Management Commentary" (Exhibit 99.2) for detailed operational analysis and forward-looking statements.
- Confirm the date and time of the investor conference call to access management's direct remarks.
- Check the Company's website (www.usana.com) for the posted exhibits and additional disclosures.